These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 9371004)
41. [Hormone replacement therapy in patients after breast cancer]. Köninger A; Kümmel S; Kimmig R MMW Fortschr Med; 2008 Oct; 150(43):32-4. PubMed ID: 19025144 [No Abstract] [Full Text] [Related]
42. Summaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force. U.S. Preventive Services Task Force Ann Intern Med; 2002 Nov; 137(10):I48. PubMed ID: 12435233 [No Abstract] [Full Text] [Related]
43. [Hormone therapy and risk for venous thromboembolism in postmenopausal women]. Lacut K; Oger E Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617 [TBL] [Abstract][Full Text] [Related]
44. [Hormone replacement therapy in menopause and risk of breast cancer]. Fournier A; Hill C; Clavel-Chapelon F Bull Cancer; 2003 Oct; 90(10):821-31. PubMed ID: 14706912 [TBL] [Abstract][Full Text] [Related]
45. Hormones and cardiovascular health in women. ESHRE Capri Workshop Group Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276 [TBL] [Abstract][Full Text] [Related]
46. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET). Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141 [TBL] [Abstract][Full Text] [Related]
47. [Replacement therapy in menopause and risk for breast tumors]. Franceschi S Ann Ist Super Sanita; 1997; 33(2):207-11. PubMed ID: 9470242 [TBL] [Abstract][Full Text] [Related]
48. Estrogen replacement therapy and the risk of thromboembolism. Fischer J S D J Med; 1995 Jul; 48(7):213-4. PubMed ID: 7660102 [No Abstract] [Full Text] [Related]
49. [Does menopausal hormonal replacement therapy increase the risk of breast cancer?]. Punnonen R Duodecim; 1996; 112(12):1110-5. PubMed ID: 10593013 [No Abstract] [Full Text] [Related]
50. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Banks E; Canfell K Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078 [TBL] [Abstract][Full Text] [Related]
51. [Risk-benefit balance of hormone replacement treatment of menopause and susceptible subjects to maximize compliance]. Lopes P; Mensier A Contracept Fertil Sex; 1998 Jun; 26(6):412-6. PubMed ID: 9691517 [No Abstract] [Full Text] [Related]
52. [Estrogen therapy and risk of thrombosis]. Lakartidningen; 1997 Jul; 94(30-31):2664. PubMed ID: 9273430 [No Abstract] [Full Text] [Related]
53. Menopause and the risk of thromboembolism. Galus M Am Fam Physician; 1997 Nov; 56(7):1723-4. PubMed ID: 9371004 [No Abstract] [Full Text] [Related]
54. [Risk of thromboembolism in contraception and hormone substitution: an update and recommendations]. van den Brûle F; Gaspard U J Pharm Belg; 2004; 59(1):38-40. PubMed ID: 15129579 [TBL] [Abstract][Full Text] [Related]
55. [Risk of venous thromboembolism during postmenopausal hormone therapy]. Pedersen AT; Ottesen B Ugeskr Laeger; 1996 Nov; 158(48):6923-4. PubMed ID: 8984757 [No Abstract] [Full Text] [Related]